Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067
Clinical trial NCT05306132 · RECRUITING
Trial details
- NCT number
- NCT05306132
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2026-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.